Director of Quality Assurance

RadioMedix Inc., a Biotechnology Company headquartered at 9701 Richmond Ave Houston, Texas 77042, is seeking a Director of Quality Assurance.  The successful candidate will play a key role in conducting Quality Assurance review of all drug products on site. The focus of the position will be to focus on high-priority projects at RadioMedix that will be integral to upcoming clinical trials. This is a newly created position with potential for significant growth.

We’re a growing company and we continue to add talent from a variety of fields. RadioMedix seeks to hire highly motivated and forward-thinking professionals interested in nuclear medicine research and development and influencing change within the Nuclear Medicine landscape

Key Responsibilities:

1. Quality Management Systems (QMS) Development:
   • Establish and maintain a robust QMS to ensure all radiopharmaceutical products comply with regulatory standards (FDA, EMA, and ICH) including 21 CFR Parts 210, 211, and 212.
   • Implement and oversee risk management processes, change control, and document management systems.
2. Regulatory Compliance:
   • Ensure strict adherence to 21 CFR Part 210 (Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs), 21 CFR Part 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals), and 21 CFR Part 212 (Current Good Manufacturing Practice for Positron Emission Tomography Drugs).
   • Prepare for and lead regulatory inspections and audits, including those from the FDA and other regulatory agencies.
   • Stay updated on evolving regulations and update company practices to maintain compliance with all relevant CFR parts.
   • Provide strategic oversight for all quality-related aspects of regulatory filings (e.g. IND.
3. Quality Control Oversight:
   • Collaborate with QC teams to validate and verify product testing, stability studies, and control strategies for radiopharmaceutical products.
   • Oversee the qualification and maintenance of laboratory equipment and facilities to ensure compliance with 21 CFR Parts 210, 211, and 212.
4. Product Release and Batch Review:
   • Approve or reject batches of radiopharmaceuticals based on quality standards and batch documentation, ensuring compliance with regulatory requirements.
   • Monitor batch records, deviation reports, and corrective actions, ensuring issues are resolved per 21 CFR guidelines.
5. Quality Events and Investigations:
   • Lead and oversee the investigation of quality events, including deviations, out-of-specification (OOS) results, complaints, and other non-conformances.
   • Conduct thorough root cause analyses for all quality events and ensure timely and effective corrective and preventive actions (CAPA).
   • Implement tracking and trending systems to monitor and reduce quality events, promoting continuo